Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
about
Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligandsChemistry and structural biology of androgen receptorEndogenous testosterone and mortality in male hemodialysis patients: is it the result of aging?Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease.Role of sex hormones in the modulation of cholangiocyte function.Sexual and gonadal dysfunction in chronic kidney disease: PathophysiologyIs Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)?Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.Low serum testosterone increases mortality risk among male dialysis patients.Prevalence of hypogonadism in male patients with renal failureRisks of testosterone replacement therapy in men.The impact of sex hormone changes on bone mineral deficit in chronic renal failure.A rational guide to reducing fracture risk in dialysis patients.Perspectives in Pediatric Pathology, Chapter 22. Testicular Involvement in Systemic Diseases.Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.Menstrual Disturbances in Premenopausal Women with End-Stage Renal Disease: A Cross-Sectional Study.Efficacy of testosterone gel in the treatment of erectile dysfunction in hypogonadal hemodialysis patients: a pilot study.Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need.
P2860
Q24680373-79671A4F-A115-4158-A402-FA6242088B67Q24685498-A1E2AF14-7CDE-419F-B8AC-2E5FE2B71554Q34405392-4C088F9F-1A61-4DE5-9886-B087AA21ED25Q34457527-039C43D2-C16E-4D92-B808-440B15D71381Q34992322-27E16E14-B4EA-4E25-AAD7-CCC096DE8A06Q35856050-D8B60934-99ED-4BF3-A9EE-255DA5B79304Q36272964-DA7C5021-068F-40C2-8D83-FA0C1A169670Q36487406-8A0C5C94-2010-4A52-9772-4322986EC700Q37123233-45620689-BDCF-4BF7-93D2-E3A006148F37Q37123780-1BE2928A-8F66-418B-A1B8-F55CBFA296EFQ37498164-DE592891-02D4-41CF-9955-52BE486CD3EBQ37585161-1CAA741D-9FE4-4DCF-9283-E93682DAA5C0Q37717790-4D6146DB-1FF3-4182-BA08-E07D8787016BQ38261745-735F8B5F-49FB-44A0-9C08-F5EE300408DCQ39857907-CFA65BD9-25B2-4784-B219-D8617446EAB9Q39975329-B25D3559-0F46-4EB0-B668-FA00742406F3Q43239050-235099E8-8C66-4148-BEED-BFCA81EEE7B3Q43580426-4935F4F8-30FF-4DE2-8462-48AB22BC4151Q48224940-2B59DBE7-FFCA-45A2-BAA2-45C2BEE41447
P2860
Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
@ast
Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
@en
type
label
Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
@ast
Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
@en
prefLabel
Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
@ast
Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
@en
P2860
P1433
P1476
Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
@en
P2093
Kirsten L Johansen
P2860
P304
P356
10.1111/J.0894-0959.2004.17307.X
P577
2004-05-01T00:00:00Z